These results reinforce our previous findings on the role of IGF1R in allergy, placing it as a potential candidate to develop novel clinical trials focused on the study of systemic IGF1R inhibitors that could be more efficient in counteracting the asthmatic response at different levels. This evidence concerns the gene IGF1R and Allergy.